PMID- 23624487 OWN - NLM STAT- MEDLINE DCOM- 20131022 LR - 20180816 IS - 1468-201X (Electronic) IS - 1355-6037 (Linking) VI - 99 IP - 13 DP - 2013 Jul TI - Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers. PG - 949-53 LID - 10.1136/heartjnl-2013-303634 [doi] AB - OBJECTIVE: The brain derived neurotrophic factor (BDNF) locus has been implicated in psychiatric and substance related disorders. Recent genome-wide association studies (GWAS) have shown strong associations between single nucleotide polymorphisms in BDNF, smoking behaviour and high body mass index (BMI). Our aim was to test whether genetic BDNF variation alters the risk of smoking related morbidity and mortality. DESIGN: Cox proportional hazards models were used to relate the BDNF rs4923461(A/G) polymorphisms to all-cause, cancer and cardiovascular mortality and cardiovascular disease (CVD) incidence adjusted for age, sex, BMI, and smoking quantity. SETTING: The Malmo Diet and Cancer Study (MDCS), a population based prospective cohort study (n=30 447). PATIENTS: We obtained complete data on 25 071 subjects, of whom 6507 were current smokers and 18 564 were non-smokers who underwent a baseline examination from 1991-1996. MAIN OUTCOME MEASURES: During a mean follow-up time of 12 years, 1049 deaths (346 cardiovascular deaths and 492 cancer deaths) and 802 incident CVD events occurred among current smokers. RESULTS: The major allele (A) of rs4923461 was significantly associated with ever having smoked (p=0.03) and high BMI (p=0.001). The A-allele was associated with risk of all-cause (HR=1.12, 95% CI 1.00 to 1.25; p<0.05) and CVD (HR=1.23, 95% CI 1.01 to 1.49; p=0.04) mortality. There was no significant association between the rs4923461 and cancer mortality or CVD incidence. CONCLUSIONS: Our data suggest that smoking- and obesity-associated variation of the BDNF gene affects the risk of death, especially due to cardiovascular causes, in smokers. Determination of the BDNF genotype in smokers may guide the need for smoking cessation interventions. FAU - Hallden, Sara AU - Hallden S AD - Department of Clinical Sciences, Lund University, Clinical Research Center, Entrance 72, Building 91, Floor 12, Malmo University Hospital, Malmo SE 205 02, Sweden. sara.hallden@med.lu.se FAU - Sjogren, Marketa AU - Sjogren M FAU - Hedblad, Bo AU - Hedblad B FAU - Engstrom, Gunnar AU - Engstrom G FAU - Narkiewicz, Krzysztof AU - Narkiewicz K FAU - Hoffmann, Michal AU - Hoffmann M FAU - Wahlstrand, Bjorn AU - Wahlstrand B FAU - Hedner, Thomas AU - Hedner T FAU - Melander, Olle AU - Melander O LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130427 PL - England TA - Heart JT - Heart (British Cardiac Society) JID - 9602087 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Age Factors MH - Aged MH - Body Mass Index MH - Brain-Derived Neurotrophic Factor/*genetics MH - Cardiovascular Diseases/*genetics/mortality/prevention & control MH - Female MH - Gene Frequency MH - Genetic Predisposition to Disease MH - Humans MH - Incidence MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Obesity/complications/*genetics/mortality MH - Odds Ratio MH - Phenotype MH - *Polymorphism, Single Nucleotide MH - Proportional Hazards Models MH - Prospective Studies MH - Risk Assessment MH - Risk Factors MH - Risk Reduction Behavior MH - Sex Factors MH - Smoking/adverse effects/*genetics/mortality MH - Smoking Cessation MH - Smoking Prevention MH - Sweden/epidemiology MH - Time Factors EDAT- 2013/04/30 06:00 MHDA- 2013/10/23 06:00 CRDT- 2013/04/30 06:00 PHST- 2013/04/30 06:00 [entrez] PHST- 2013/04/30 06:00 [pubmed] PHST- 2013/10/23 06:00 [medline] AID - heartjnl-2013-303634 [pii] AID - 10.1136/heartjnl-2013-303634 [doi] PST - ppublish SO - Heart. 2013 Jul;99(13):949-53. doi: 10.1136/heartjnl-2013-303634. Epub 2013 Apr 27.